Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

NeuroOp Guru

The Residency Report

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

IOL Advances

Imaging

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Interventional Glaucoma

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

News

All News

Contributors

Money Matters

Media

All Videos

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

Articles

Prednisolone acetate ophthalmic suspension, 1% sterile references Pred Forte from Allergan.

FDA approves prednisolone acetate ophthalmic suspension for treating steroid-responsive ocular inflammation

Lamivudine could provide an oral option to more effectively treat DME at a lower cost to patients

HIV drug lamivudine shows promise in treating diabetic macular edema

Harrow expects BYQLOVI to be commercially available in Q4 2025. 

Formosa Pharmaceuticals grants Harrow US commercial rights to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia

Qlaris Bio announces development of QLS-111-FDC

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

About

Advertise

Privacy

Editorial Info

Editorial Board

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times – Clinical Insights for Eye Specialists

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Glaucoma

View

Improving Vision with Innovative Intraocular Lenses for Cataract Treatment

Videos

Neda Shamie, MD, discusses two patient cases and highlights the factors to consider when choosing intraocular lenses for cataract surgery. She emphasized the importance of considering patient factors and needs in selecting the right lens option.

Neda Shamie, MD, presents a case of a 65-year-old college professor with monovision who sought freedom from glasses following cataract surgery.

Patient Case #1: Choosing a Cataract Lens for a Patient with Monovision

Neda Shamie, MD, discusses the factors to consider when selecting cataract lenses for patients with monovision and emphasized how light adjustable lenses offer flexibility in correcting vision to the desired target after surgery.

Patient Case #1: Impressions and Takeaways

Neda Shamie, MD, reviews the case of a 56-year-old photographer who desires excellent midrange and distance vision with high contrast sensitivity.

Patient Case #2: Choosing a Cataract Lens for a Patient Needing Excellent Midrange and Distance Vision

Neda Shamie, MD, explains how her practice has established procedures for incorporating light adjustable lenses into their cataract surgery workflow.

Implementing the Light Adjustable Lens in Practice

Implementing the Light Adjustable Lens in Practice

EP: 1.Patient Case #1: Choosing a Cataract Lens for a Patient with Monovision

EP: 2.Patient Case #1: Impressions and Takeaways

EP: 3.Patient Case #2: Choosing a Cataract Lens for a Patient Needing Excellent Midrange and Distance Vision

EP: 4.Implementing the Light Adjustable Lens in Practice

Newsletter